← FDA Drug Approvals (Drugs@FDA)

CLARAVIS

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2003-04-11

Drug application

FDA Application #

ANDA076356

Application type

Abbreviated New Drug Application (Generic)

Brand name

CLARAVIS

Generic name

ISOTRETINOIN

Active ingredients

ISOTRETINOIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS USA

Manufacturer

Teva Pharmaceuticals USA, Inc.

First approval

2003-04-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown